1. Exclusive Field of Use Licensing
Advanced Patent Law Institute
December 6, 2018
Ron Laurie
Suzanne Bell
Gillian Thackray

2. Exclusive Field of Use Licensing
Business Model
(Client Perspective)
Implementation Matters
(Corporate Counsel Perspective)
Legal Issues
(Outside Counsel Perspective)

3. Presenters Ron Laurie Inflexion Point Strategy
In 2004, Ron he launched Inflexion Point Strategy, the first IP investment bank. With offices in Silicon Valley, Taiwan and Singapore, Inflexion Point advises technology companies and institutional investors around the world in acquiring, divesting and investing in IP-rich companies, businesses units and technologies, and IP assets in the form of patent portfolios, exclusive field-of-use rights and related know- how.
Inflexion Point’s mission is to extract the unrealized value of strategic IP by increasing corporate valuation in M&A transactions, by building a defensive shield against litigious competitors and by generating topline revenue via creative exclusive field-of-use licensing programs.
Suzanne Bell Covington & Burling LLP
Suzanne Bell has more than 20 years of experience representing some of the world’s most prominent technology companies in their most significant technology and intellectual property transactions. Recognized as a leading practitioner in Chambers USA for her "wealth of experience," clients describe her as "service-oriented, delivering high-quality work product in a practical and friendly manner."
Ms. Bell focuses on technology and IP transactions—with an emphasis on complex strategic alliances—for a wide range of software, electronics, AI, IoT, autonomous vehicle, telecommunications, cloud computing, digital media, Internet, fintech, digital health, and clean technology companies. Her practice also includes: strategic intellectual property asset purchases and sales; technology mergers, acquisitions, and spin-offs; and intellectual property litigation settlement agreements.
Gillian Thackray Thermo Fisher Scientific
Gillian Thackray is Vice President, Chief IP Counsel at Thermo Fisher Scientific. An an expert IP strategist and award-winning lawyer, Gillian has protected innovations for some of the world’s most high-tech innovators. Her multi-faceted approach integrates law, business, and practicality to help business partners reach their goals. She is registered to practice at the USPTO, and admitted in California.
Her specialties include: Business Strategy, Maximizing Intellectual Property Value, New Product Development, Licensing, Risk Mitigation, Trademark, Technology Transactions, Complex Civil Litigation, Arbitration & Mediation, Negotiations, and Regulatory Compliance.